Skip to the page

Data / Form D filings / Layka Bio Inc

Layka Bio Inc: Form D filing

Layka Bio Inc, a biotechnology company in Newton Highlands, MA, filed a Form D with the SEC in 2026. The latest, on August 7, 2026, reports $300,000 sold of a $5 million offering to 1 investor.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
19 TERRACE AVE, Newton Highlands, MA, 02461
Phone
(617) 319-9180
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2026
Revenue range
No Revenues
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2148283

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Aug 7, 2026New notice$5,000,000$300,000$4,700,0001Jul 27, 2026sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Ante S LundbergExecutive Officer, Director, Promoter
Matthew MeyersonPromoter
Stephen KronPromoter

Other biotechnology companies in Massachusetts that filed recently

Every Form D from the week of Aug 3, 2026 · All recent filings in Massachusetts · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what Layka Bio Inc reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.